High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)

Publisher： Karger

E-ISSN： 1421-9786|28|3|266-275

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.28, Iss.3, 2009-07, pp. : 266-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ASTEROID trial: coronary plaque regression with high-dose statin therapy

By Chhatriwalla Adnan K   Nicholls Stephen J   Nissen Steven E  

Future Cardiology, Vol. 2, Iss. 6, 2006-11 ,pp. : 651-654

Future Medicine

Access to resources Recommend Favorite

Neuroprotection as Initial Therapy in Acute Stroke

By  

Cerebrovascular Diseases, Vol. 8, Iss. 1, 1998-01 ,pp. : 59-72

Karger

Access to resources Recommend Favorite

Deterioration in Acute Ischemic Stroke as the Target for Neuroprotection

By  

Cerebrovascular Diseases, Vol. 21, Iss. 2, 2006-05 ,pp. : 80-88

Karger

Access to resources Recommend Favorite

Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review

By  

Cerebrovascular Diseases, Vol. 36, Iss. 3, 2013-10 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Acute Transient Cerebral Toxicity Associated with Administration of High-Dose Methotrexate

By  

Medical Principles and Practice, Vol. 14, Iss. 3, 2005-04 ,pp. : 202-204

Karger

Access to resources Recommend Favorite